Back to Agenda
Regulatory Affairs: Part 1: The IND – Investigational New Drug Application
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
Kevin Daniel Healy, PhD
Senior Vice President Regulatory Affairs
Entrada Therapeutics, United States
Regulatory Affairs: Part 1: The IND – Investigational New Drug Application
Have an account?